Compare BCAL & ABSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCAL | ABSI |
|---|---|---|
| Founded | 2001 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 528.7M | 577.4M |
| IPO Year | N/A | 2021 |
| Metric | BCAL | ABSI |
|---|---|---|
| Price | $19.22 | $3.56 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $20.00 | $7.98 |
| AVG Volume (30 Days) | 230.7K | ★ 4.1M |
| Earning Date | 01-28-2026 | 11-12-2025 |
| Dividend Yield | ★ 2.10% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.92 | N/A |
| Revenue | ★ $187,714,000.00 | $2,815,000.00 |
| Revenue This Year | $73.26 | $10.72 |
| Revenue Next Year | $3.29 | $437.79 |
| P/E Ratio | $9.93 | ★ N/A |
| Revenue Growth | ★ 139.72 | N/A |
| 52 Week Low | $11.87 | $2.01 |
| 52 Week High | $20.47 | $6.33 |
| Indicator | BCAL | ABSI |
|---|---|---|
| Relative Strength Index (RSI) | 48.76 | 52.26 |
| Support Level | $18.87 | $3.37 |
| Resistance Level | $20.00 | $3.79 |
| Average True Range (ATR) | 0.42 | 0.30 |
| MACD | -0.13 | 0.02 |
| Stochastic Oscillator | 21.56 | 34.42 |
California BanCorp is a registered bank holding company headquartered in San Diego, California. The Bank offers a range of financial products and services to individuals, professionals, and small to medium-sized businesses through its 14 branch offices and four loan production offices serving Northern and Southern California. The Bank's solutions-driven, relationship-based approach to banking provides accessibility to decision-makers and enhances value through partnerships with its clients. The company has one operating segment: Commercial Banking.
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.